← back to search

Heather E. Fleming

Massachusetts Institute of Technology · US
Area of research
Immunology · Molecular Biology
Research interest
Research interests include T-cell and B-cell Immunology, CRISPR and Genetic Engineering, Advanced biosensing and bioanalysis techniques, and Liver physiology and pathology.
h-index
28
citations
5,486
works
63
NIH funding
primary concept
email

Recent publications

Image-guided injectable niche for hepatocyte transplantation
Cell Biomaterials 2026cited by 1position: middledoi
Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies
Science 2024cited by 157position: middledoi
Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses
Science Advances 2024cited by 31position: middledoi
Inhalable point-of-care urinary diagnostic platform
Science Advances 2024cited by 25position: middledoi
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system
Proceedings of the National Academy of Sciences 2024cited by 15position: middledoi
CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics
Nature Nanotechnology 2023cited by 145position: middledoi
CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
Journal of Visualized Experiments 2023cited by 2position: middledoi
A single-cell liver atlas of Plasmodium vivax infection
Cell Host & Microbe 2022cited by 96position: middledoi
Conditional Antimicrobial Peptide Therapeutics
ACS Nano 2022cited by 68position: middledoi
A vascularized model of the human liver mimics regenerative responses
Proceedings of the National Academy of Sciences 2022cited by 64position: middledoi
Microenvironment-triggered multimodal precision diagnostics
Nature Materials 2021cited by 70position: middledoi
Synthetic Circuit-Driven Expression of Heterologous Enzymes for Disease Detection
ACS Synthetic Biology 2021cited by 11position: middledoi
Gene signatures and host-parasite interactions revealed by dual single-cell profiling of <i>Plasmodium vivax</i> liver infection
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 2position: middledoi
Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling
Science Translational Medicine 2020cited by 98position: middledoi
Controlled Apoptosis of Stromal Cells to Engineer Human Microlivers
Advanced Functional Materials 2020cited by 17position: middledoi
Tissue Engineering: Controlled Apoptosis of Stromal Cells to Engineer Human Microlivers (Adv. Funct. Mater. 48/2020)
Advanced Functional Materials 2020cited by 3position: middledoi
Hepatic tissue engineering
Elsevier eBooks 2020cited by 3position: middledoi
Synthetic and living micropropellers for convection-enhanced nanoparticle transport
Science Advances 2019cited by 149position: middledoi
Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes
Nanoscale 2019cited by 47position: middledoi
Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers
Cell Metabolism 2019cited by 16position: middledoi
In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites
Cell Host & Microbe 2018cited by 153position: middledoi
Protease activity sensors noninvasively classify bacterial infections and antibiotic responses
EBioMedicine 2018cited by 28position: middledoi
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
Science Translational Medicine 2017cited by 168position: middledoi
Development of Light‐Activated CRISPR Using Guide RNAs with Photocleavable Protectors
Angewandte Chemie International Edition 2016cited by 195position: middledoi
Development of Light‐Activated CRISPR Using Guide RNAs with Photocleavable Protectors
Angewandte Chemie 2016cited by 34position: middledoi
Extracellular matrix microarrays to study inductive signaling for endoderm specification
Acta Biomaterialia 2016cited by 32position: middledoi
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
Nature Protocols 2015cited by 147position: middledoi
Pluripotent stem cell-derived hepatocyte-like cells
Biotechnology Advances 2014cited by 287position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sangeeta N. Bhatia · Broad Institute21 papers (2014–2024)Sangeeta N. Bhatia · Massachusetts Institute of Technology5 papers (2017–2026)Sandra March · Broad Institute5 papers (2015–2024)Liliana Mâncio-Silva · Massachusetts Institute of Technology5 papers (2018–2024)Liangliang Hao · Massachusetts Institute of Technology5 papers (2021–2024)Renee T. Zhao · Massachusetts Institute of Technology4 papers (2021–2024)Vyas Ramanan · Massachusetts Institute of Technology4 papers (2015–2017)Arnav Chhabra · Massachusetts Institute of Technology4 papers (2020–2022)Nil Gural · Massachusetts General Hospital4 papers (2015–2022)Christopher S. Chen · Boston University4 papers (2017–2022)Amanda X. Chen · Massachusetts Institute of Technology4 papers (2017–2020)Piyush Jain · Massachusetts Institute of Technology3 papers (2016–2019)Jesse D. Kirkpatrick · Massachusetts Institute of Technology3 papers (2020–2024)Edward K.W. Tan · Massachusetts Institute of Technology3 papers (2023–2024)Carmen Martin-Alonso · Massachusetts Institute of Technology3 papers (2020–2024)Ava P. Soleimany · Massachusetts Institute of Technology3 papers (2019–2021)Apekshya Panda · Broad Institute3 papers (2016–2019)Charles M. Rice · Rockefeller University3 papers (2015–2024)Stuart S. Levine · Massachusetts Institute of Technology3 papers (2018–2022)Vincent L. Butty · Massachusetts Institute of Technology3 papers (2018–2022)